#lung-cancer

A Cell study from the Francis Crick Institute links sensory nerve signaling to weaker anti-tumor immunity in lung cancer, pointing to a potential new way to strengthen immunotherapy.

Researchers at MD Anderson Cancer Center report that some relapsed lung cancer cells switch on YAP1 only after chemotherapy, a finding that could help explain why treatment-resistant disease returns.

New research highlighted by Medical Xpress suggests that diets rich in fruits, vegetables, and whole grains may also expose younger non-smokers to pesticides linked to lung cancer risk.

Prospective data show proton beam therapy improves survival while sparing healthy tissue and preserving quality of life in lung cancer patients.

Researchers identify miR-149-5p as a key driver of immune escape in bronchial lesions that can progress to squamous cell lung cancer.

New clinical data shows proton beam therapy delivers strong survival rates for advanced lung cancer while reducing damage to healthy tissue.

Scientists discover how premalignant lung cells suppress immune surveillance, revealing potential targets for intercepting cancer before it fully develops.